R Kure Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-03-2024
- Paid Up Capital ₹ 0.10 M
as on 31-03-2024
- Company Age 19 Year, 28 Days
- Last Filing with ROC 31 Mar 2008
About R Kure Pharmaceuticals
- CIN/LLPIN
U24231UP2005PTC031033
- Company No.
031033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2005
- Date of AGM
30 Sep 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at R Kure Pharmaceuticals?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Suresh Vaish | Director | 01-Dec-2005 | Current |
Dinesh Vaish | Director | 01-Feb-2008 | Current |
Financial Performance of R Kure Pharmaceuticals.
Enhance accessibility to R Kure Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of R Kure Pharmaceuticals?
Unlock access to R Kure Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at R Kure Pharmaceuticals?
Unlock and access historical data on people associated with R Kure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R Kure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R Kure Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.